Physician profile
Bojan Zoric
NPI 1306879093
$19,719.66
in general payments reported to CMS, 2019-2025
11 companies · $7,641 in 2025
The $7,641 reported for 2025 was more than what 85% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.18 · 2020: $11.22 · 2022: $222 · 2023: $174 · 2024: $12K · 2025: $7,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,975.00 |
| Food and Beverage | $419.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $19,259.78 | 2020-2025 | Accu-Pass, Q-Fix, Cap-Fix |
| Stryker Corporation | $146.20 | 2022 | |
| Depuy Synthes Sales INC. | $139.97 | 2019-2025 | Orthovisc, Monovisc, Vapr |
| Ethicon US, LLC | $53.02 | 2019-2024 | Vistaseal, Surgicel Nu-Knit, Stratafix |
| Bioventus LLC | $23.55 | 2025 | Exogen Ultrasound Bone Healing System |
| Fidia Pharma USA INC. | $19.43 | 2024 | Hyalgan, Triluron, Hymovis |
| Pacira Pharmaceuticals Incorporated | $17.94 | 2019 | |
| Acumed LLC | $17.08 | 2024 | Inframe Implant |
| Orthofix Medical, INC. | $17.03 | 2022 | |
| Endo Pharmaceuticals INC. | $14.16 | 2019 | |
| Avanos Medical | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bojan Zoric listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.